Clonal Cell Dominance observed in a gene therapy patient in France during clinical trial
Initial information provided by the French Medicines Agency AFSSAPS, oral presentation by the investigator during the 12th Annual Meeting of the American Society of Gene Therapy on 27th May 2009
A biological observation termed clonal cell dominance has been made in a gene therapy patient in France treated with cells modified by what was presumed to be a safer lentiviral vector.
New information on vaccination – The database on suspected cases of adverse events following immunisation is now on-line
The Paul-Ehrlich-Institut is the first marketing authorisation authority for medicinal products in Europe which provides free access to an online database with detailed information on suspected cases of adverse events following immunisation (www.pei.de/adr-database). Its features include targeted search for particular reactions or vaccines. Data last updated: 31 August 2007.
